Overview
Aermai Biotech is an innovative drug developer.
Funding
Amounts as reported; USD estimates shown only when they matchListed 2 funding records.
No chartable funding estimates yet.
2 listed records lack a clear date or positive USD estimate for the chart.
| Date | Amount | Investors | Sources |
|---|---|---|---|
| Sep 2, 2022 | Undisclosed · Strategic | 先声药业, 协耀投资, 苏州领军创投 | No source link |
Evidence No source brief is attached to this record. Sources · 0
| |||
| Mar 29, 2022 | Undisclosed · Strategic | 中财予飞（北京）私募基金管理 | No source link |
Evidence No source brief is attached to this record. Sources · 0
| |||
Select ▸ on a row to see its source brief and links.
Valuation
Amounts as reported; USD estimates shown only when they matchListed 2 valuation records.
No chartable valuation estimates yet.
2 listed records lack a clear date or positive USD estimate for the chart.
| Date | Amount | Investors | Sources |
|---|---|---|---|
| Sep 2, 2022 | — · Strategic | 先声药业, 协耀投资, 苏州领军创投 | No source link |
Evidence No source brief is attached to this record. Sources · 0
| |||
| Mar 29, 2022 | — · Strategic | 中财予飞（北京）私募基金管理 | No source link |
Evidence No source brief is attached to this record. Sources · 0
| |||
Select ▸ on a row to see its source brief and links.
Revenue
Amounts as reported; USD estimates shown only when they matchNo revenue records are listed yet.
No revenue rows to list.
Team, products & investors
Explore
More Industry apps companies
Sources · 0Sources & provenance
English text is maintained separately from the original record. Consult the original source before citing a fact.
No source links are available for this profile.
Original source text
Names may use phonetic renderings when no English name is supplied. The original wording is retained below.
创新药物研发商 阿尔脉生物是一家创新药物研发商